Follow the Data: Applying PSI to inflammation of CAR T-cell product correlates to Grade 3+ CRS, pre-infusion1

Research Area: Inflammatory & autoimmune disease

Development Stage: Prediction

Goal: Preinfusion prediction of in vivo CRS in CAR-T patients, not possible with legacy technologies

[unex_ce_button id="content_10khx0ih9,column_content_611g46odk" button_text_color="#ffffff" button_font="bold" button_font_size="18px" button_width="auto" button_alignment="right" button_text_spacing="1px" button_bg_color="#24b7d8" button_padding="15px 30px 15px 30px" button_border_width="0px" button_border_color="#24b7d8" button_border_radius="0px" button_text_hover_color="#ffffff" button_text_spacing_hover="1px" button_bg_hover_color="#84c9d8" button_border_hover_color="#84c9d8" button_link="" button_link_type="url" button_link_target="_blank" has_container="" in_column="1"]Request a seminar
to follow our data >[/ce_button]

How our single-cell systems are making a difference

Solution:  IsoPlexis' PSI is able to stratify severe CRS occurence in CAR-T patients

Finding: PSI of the pre-infusion CAR-T product was found to associate with in vivo CRS

Follow the data

Higher CAR-T product PSI was found to statistically associate with grade 3+ CRS (p = 0.0174). PSI was measured across CD4+ and CD8+ samples from 20 patients.

In particular, there were large increases in the production of effector and stimulatory cytokines in the 3+ CRS cohort. These results suggest that the combination of frequency and cytokine production levels of polyfunctional T cells in the product associate with toxicity to treatment with CAR T cells.1

[unex_ce_button id="content_om95el0ye,column_content_g32kkdowi" button_text_color="#424242" button_font="bold" button_font_size="18px" button_width="auto" button_alignment="right" button_text_spacing="1px " button_bg_color="#c9c9c9" button_padding="15px 30px 15px 30px" button_border_width="0px" button_border_color="#c9c9c9" button_border_radius="0px" button_text_hover_color="#424242" button_text_spacing_hover="1px" button_bg_hover_color="#e8e8e8" button_border_hover_color="#e8e8e8" button_link="" button_link_type="url" button_link_target="_blank" has_container="" in_column="1"]Download application highlight
to learn more >[/ce_button]

IsoPlexis finds critical differences

The CAR-T product PSI association with in vivo grade 3+ CRS was strengthened when the metric was combined with day 0 IL-15 levels in the patients (p = 0.085). IL-15 levels in the blood were measured by ELISA.1